A detailed history of Metis Global Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Metis Global Partners, LLC holds 10,829 shares of BDX stock, worth $2.47 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,829
Previous 10,496 3.17%
Holding current value
$2.47 Million
Previous $2.45 Million 6.4%
% of portfolio
0.08%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$221.47 - $242.41 $73,749 - $80,722
333 Added 3.17%
10,829 $2.61 Million
Q2 2024

Aug 06, 2024

BUY
$225.07 - $246.17 $3,376 - $3,692
15 Added 0.14%
10,496 $2.45 Million
Q1 2024

May 06, 2024

SELL
$233.45 - $247.73 $275,937 - $292,816
-1,182 Reduced 10.13%
10,481 $2.59 Million
Q4 2023

Feb 06, 2024

SELL
$232.24 - $267.23 $219,466 - $252,532
-945 Reduced 7.5%
11,663 $2.84 Million
Q3 2023

Nov 07, 2023

BUY
$254.9 - $283.59 $521,525 - $580,225
2,046 Added 19.37%
12,608 $3.26 Million
Q2 2023

Aug 07, 2023

SELL
$238.39 - $265.32 $108,705 - $120,985
-456 Reduced 4.14%
10,562 $2.79 Million
Q1 2023

May 08, 2023

BUY
$229.71 - $259.35 $699,696 - $789,980
3,046 Added 38.21%
11,018 $2.73 Million
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $687,613 - $809,266
3,150 Added 65.33%
7,972 $2.03 Million
Q3 2022

Nov 08, 2022

BUY
$51.03 - $264.23 $8,777 - $45,447
172 Added 3.7%
4,822 $1.07 Million
Q2 2022

Aug 08, 2022

BUY
$234.74 - $275.42 $30,985 - $36,355
132 Added 2.92%
4,650 $1.15 Million
Q1 2022

May 03, 2022

BUY
$243.64 - $270.48 $490,447 - $544,476
2,013 Added 80.36%
4,518 $1.2 Million
Q4 2021

Feb 11, 2022

BUY
$230.08 - $250.94 $576,350 - $628,604
2,505 New
2,505 $630,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.